KENDRA DRAKE: Open Payments
NPI 1639621667 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,992 in 141 payments from 28 companies in 2025. Trend: 2023 $2,054 · 2024 $3,075 · 2025 $2,992
Food & beverage: $2,708Education: $284
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $324 |
| AstraZeneca Pharmaceuticals LP | 12 | $284 |
| Astellas Pharma US Inc | 8 | $283 |
| Novartis Pharmaceuticals Corporation | 15 | $253 |
| PFIZER INC. | 16 | $253 |
| Daiichi Sankyo Inc. | 15 | $233 |
| ABBVIE INC. | 11 | $188 |
| Merck Sharp & Dohme LLC | 9 | $183 |
| Regeneron Healthcare Solutions, Inc. | 3 | $157 |
| Incyte Corporation | 8 | $135 |
Products named: KEYTRUDA, TAGRISSO, LIBTAYO, Vyloy, Enhertu, DARZALEX, XTANDI, SCEMBLIX.
Industry payments across KY — which companies pay providers there.
